3 In 1 (cTnI/Myo/CK-MB) Reagent Kit (Quantitative)

Product Name: 3 In 1 (cTnI/Myo/CK-MB)  Reagent Kit (Quantitative)

Method: Laternal-Flow technology (Fluorescent Immunochromatographic

Product Models: 5 tests/box, 25 tests/box, 40 tests/box, 100 tests/box

CFDA Registration No.: 20152400171 by CFDA

Certification: CE, ISO13485, ISO9001

Matching Equipment's: Solid Phase Fluorescence Immunoassay System (KOFA Brand).

Introduction: This reagent kit is base on fluorescent chromatographic technology, supporting the quantitative rapid test of Myo/cTnI/CK-MB level in the serum/plasma. The combined testing of Myo/cTnI/CK-MB is used to diagnose myocardial injury and infarction.

3 In 1 (Myo/cTnI/CK-MB Technical Parameters:

The advantages of 3 In 1 (Myo/cTnI/ CK-MB):

1. Advanced fluoroimmunoassay quantitative testing platform, make accurate and quantitative rapid test of Myo/cTnI/CK-MB level available

2. Low cost and rapid test, can get the quantitative and reliable results in 15 minutes, shorten the testing turnaround time.

3. The testing results of this Myo/cTnI/CK-MB kit have good correlation with that of Roche Diagnostics (compared with thousands of samples).

4. Simple operation and rapid test, can meet the need of various departments.

5. The combined testing of Myo, cTnI and CK-MB is more convenient, accurate and efficient than single testing items, making the patients well-treated in the shorter time.

Applicable Departments: Departments of cardiology, surgery, geriatrics, respiratory, pediatrics, obstetrics, emergency ward and ICU.